Medindia

X

Aduromed Elects Richard W. Wolfe to Board of Directors

Monday, December 15, 2008 General News J E 4
Advertisement
BETHEL, Conn., Dec. 15 Aduromed Industries, Inc.(OTC Bulletin Board: ADRM), a provider of innovative technology and servicesfor the onsite treatment and disposal of regulated medical waste, todayannounced that Richard W. Wolfe has been elected to the Company's board ofdirectors. Mr. Wolfe has 30 years of executive leadership, extensive publicpolicy and political advocacy experience, and is recognized for designing andimplementing innovative programs in the health care field. He currently ownshealth care companies throughout the southeastern US, including SubacuteServices, Inc. and Sunrise Health and Rehabilitation Center, which providesubacute, long-term care, home health care and related services. Previously,he was CEO, Vice Chairman of the Board, and Chairman of the ExecutiveCommittee of a NYSE-listed hospital company providing acute care, behavioral,rehabilitation and long term acute care services. Prior to that, he was apartner in the Dillard & Wolfe, PC law firm where he was Counsel to theMajority Leader of the Georgia Senate. Mr. Wolfe has his J.D. from the WoodrowWilson College of Law in Atlanta and has a B.A. from Western KentuckyUniversity where he serves as a member of the Advisory Board and as a visitinglecturer in the Gordon Ford School of Business.

Mr. Joseph Esposito, Chairman of the Board of Directors, commented,"Richard Wolfe is an outstanding addition to the Aduromed board. His provenleadership, deep understanding of the healthcare public policy and advocacyarena and his ability to develop innovative programs has earned him broadrecognition. We value this forward thinking approach and know that hisexpertise and reputation will augment our board as we develop and execute ourstrategic plan."

Mr. Wolfe added, "It is clear to me that Aduromed has innovative andindustry-leading technology and, I am eager to assist them as they implementtheir growth initiatives. I believe their integrated technology addresses theissues of most concern to healthcare organizations, which are seeking easy toimplement solutions for handling challenges associated with regulated medicalwaste that are cost effective, mitigate risk, and enhance institutions' Greenprofiles and standing in host communities. I am honored to join the Aduromedboard and look forward to helping them deliver value to their shareholders."

About Aduromed Industries, Inc.

Aduromed Industries, Inc. is a provider of innovative technology andservices for the onsite treatment and disposal of regulated medical waste.Aduromed's flagship MedClean(R) Series systems are fully integrated, turnkeytechnology solutions that enable hospitals and other healthcare providers tosafely, efficiently and cost-effectively convert bio-hazardous regulatedmedical waste into sterile, unrecognizable material suitable for disposal asmunicipal solid waste. Aduromed was founded in 1997 with corporateheadquarters, research and development and distribution facilities located inBethel, Connecticut. Further information on Aduromed can be found athttp://www.aduromed.com and in filings with the Securities and ExchangeCommission found at http://www.sec.gov.

Statements about our future expectations are "forward-looking statements"within the meaning of applicable Federal Securities Laws, and are notguarantees of future performance. When used herein, the words "may," "will,""should," "anticipate," "believe," "appear," "intend," "plan," "expect,""estimate," "approximate," and similar expressions are intended to identifysuch forward-looking statements. These statements involve risks anduncertainties inherent in our business, including those set forth in our mostrecent Annual Report on Form 10-K for the year ended December 31, 2007, filedwith the SEC on March 31, 2008, and other filings with the SEC, and aresubject to change at any time. Our actual results could differ materially fromthese forward-looking statements. We undertake no obligation to updatepublicly any forward-looking statement.Contacts: Aduromed Industries, Inc. Investor Contact: Kevin Dunphy Cameron Donahue Chief Financial Officer Hayden IR (203) 798-1080 (651) 653-1854 kdunphy@aduromed.com cameron@haydenir.com

SOURCE Aduromed Industries, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Cylene Pharmaceuticals Initiates Phase II Clinical...
S
HUYA Bioscience Announces Agreement to Provide Sch...